CANADIAN SOLAR INC (CSIQ)

CA1366351098 - Common Stock

11.5  +0.74 (+6.88%)

After market: 11.56 +0.06 (+0.52%)

Fundamental Rating

2

Overall CSIQ gets a fundamental rating of 2 out of 10. We evaluated CSIQ against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of CSIQ have multiple concerns. CSIQ has a valuation in line with the averages, but on the other hand it scores bad on growth.



2

1. Profitability

1.1 Basic Checks

CSIQ had negative earnings in the past year.
CSIQ had a negative operating cash flow in the past year.
Of the past 5 years CSIQ 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: CSIQ reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of 0.30%, CSIQ perfoms like the industry average, outperforming 45.37% of the companies in the same industry.
CSIQ's Return On Equity of 1.38% is in line compared to the rest of the industry. CSIQ outperforms 47.22% of its industry peers.
CSIQ has a Return On Invested Capital (2.03%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CSIQ is significantly below the industry average of 11.24%.
Industry RankSector Rank
ROA 0.3%
ROE 1.38%
ROIC 2.03%
ROA(3y)2.08%
ROA(5y)2.33%
ROE(3y)9.45%
ROE(5y)10%
ROIC(3y)3.73%
ROIC(5y)4.08%

1.3 Margins

The Profit Margin of CSIQ (0.56%) is comparable to the rest of the industry.
CSIQ's Profit Margin has declined in the last couple of years.
The Operating Margin of CSIQ (2.77%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CSIQ has declined.
The Gross Margin of CSIQ (16.22%) is worse than 82.41% of its industry peers.
In the last couple of years the Gross Margin of CSIQ has declined.
Industry RankSector Rank
OM 2.77%
PM (TTM) 0.56%
GM 16.22%
OM growth 3Y-4.74%
OM growth 5Y-13.03%
PM growth 3Y-5.15%
PM growth 5Y-10.67%
GM growth 3Y-5.38%
GM growth 5Y-4.07%

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CSIQ is destroying value.
CSIQ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CSIQ has an Altman-Z score of 0.83. This is a bad value and indicates that CSIQ is not financially healthy and even has some risk of bankruptcy.
CSIQ has a Altman-Z score of 0.83. This is in the lower half of the industry: CSIQ underperforms 72.22% of its industry peers.
A Debt/Equity ratio of 1.04 is on the high side and indicates that CSIQ has dependencies on debt financing.
With a Debt to Equity ratio value of 1.04, CSIQ is not doing good in the industry: 86.11% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF N/A
Altman-Z 0.83
ROIC/WACC0.48
WACC4.24%

2.3 Liquidity

A Current Ratio of 1.04 indicates that CSIQ should not have too much problems paying its short term obligations.
CSIQ has a Current ratio of 1.04. This is amonst the worse of the industry: CSIQ underperforms 89.81% of its industry peers.
CSIQ has a Quick Ratio of 1.04. This is a bad value and indicates that CSIQ is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.82, CSIQ is not doing good in the industry: 86.11% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 0.82

3

3. Growth

3.1 Past

The earnings per share for CSIQ have decreased strongly by -101.80% in the last year.
Measured over the past years, CSIQ shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -30.77% on average per year.
EPS 1Y (TTM)-101.8%
EPS 3Y-26.43%
EPS 5Y-30.77%
EPS Q2Q%-196.87%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.34%

3.2 Future

CSIQ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 81.59% yearly.
CSIQ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.59% yearly.
EPS Next Y267.99%
EPS Next 2Y158.88%
EPS Next 3Y155.63%
EPS Next 5Y81.59%
Revenue Next Year22.66%
Revenue Next 2Y18.19%
Revenue Next 3Y22.22%
Revenue Next 5Y13.59%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

5

4. Valuation

4.1 Price/Earnings Ratio

CSIQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 6.94, the valuation of CSIQ can be described as very cheap.
99.07% of the companies in the same industry are more expensive than CSIQ, based on the Price/Forward Earnings ratio.
CSIQ is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.94

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CSIQ is valued cheaply inside the industry as 93.52% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.52

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CSIQ's earnings are expected to grow with 155.63% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y158.88%
EPS Next 3Y155.63%

0

5. Dividend

5.1 Amount

CSIQ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CANADIAN SOLAR INC

NASDAQ:CSIQ (12/20/2024, 8:04:08 PM)

After market: 11.56 +0.06 (+0.52%)

11.5

+0.74 (+6.88%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)12-05 2024-12-05/bmo
Earnings (Next)N/A N/A
Inst Owners53.53%
Inst Owner Change10.11%
Ins Owners21.2%
Ins Owner ChangeN/A
Market Cap760.96M
Analysts72.22
Price Target19.13 (66.35%)
Short Float %22.23%
Short Ratio4.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)664.3%
Min EPS beat(2)-62.29%
Max EPS beat(2)1390.88%
EPS beat(4)1
Avg EPS beat(4)269.97%
Min EPS beat(4)-187.15%
Max EPS beat(4)1390.88%
EPS beat(8)5
Avg EPS beat(8)174.12%
EPS beat(12)8
Avg EPS beat(12)147.77%
EPS beat(16)11
Avg EPS beat(16)152.6%
Revenue beat(2)2
Avg Revenue beat(2)1.15%
Min Revenue beat(2)1.08%
Max Revenue beat(2)1.23%
Revenue beat(4)2
Avg Revenue beat(4)-2.42%
Min Revenue beat(4)-10.98%
Max Revenue beat(4)1.23%
Revenue beat(8)3
Avg Revenue beat(8)-3.34%
Revenue beat(12)4
Avg Revenue beat(12)-3.88%
Revenue beat(16)7
Avg Revenue beat(16)-2.58%
PT rev (1m)-7.75%
PT rev (3m)-18.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)37.94%
EPS NY rev (1m)-12.07%
EPS NY rev (3m)-71.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.34%
Revenue NY rev (1m)-11.34%
Revenue NY rev (3m)-45.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.94
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.29
P/tB 0.29
EV/EBITDA 6.52
EPS(TTM)-0.09
EYN/A
EPS(NY)1.66
Fwd EY14.4%
FCF(TTM)-31.39
FCFYN/A
OCF(TTM)-5.64
OCFYN/A
SpS98.43
BVpS40.15
TBVpS39.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.3%
ROE 1.38%
ROCE 2.75%
ROIC 2.03%
ROICexc 2.61%
ROICexgc 2.62%
OM 2.77%
PM (TTM) 0.56%
GM 16.22%
FCFM N/A
ROA(3y)2.08%
ROA(5y)2.33%
ROE(3y)9.45%
ROE(5y)10%
ROIC(3y)3.73%
ROIC(5y)4.08%
ROICexc(3y)4.8%
ROICexc(5y)5.21%
ROICexgc(3y)4.81%
ROICexgc(5y)5.24%
ROCE(3y)6.04%
ROCE(5y)7.13%
ROICexcg growth 3Y8.82%
ROICexcg growth 5Y-16.54%
ROICexc growth 3Y8.92%
ROICexc growth 5Y-16.47%
OM growth 3Y-4.74%
OM growth 5Y-13.03%
PM growth 3Y-5.15%
PM growth 5Y-10.67%
GM growth 3Y-5.38%
GM growth 5Y-4.07%
F-Score1
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF N/A
Debt/EBITDA 5.67
Cap/Depr 555.03%
Cap/Sales 26.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.04
Quick Ratio 0.82
Altman-Z 0.83
F-Score1
WACC4.24%
ROIC/WACC0.48
Cap/Depr(3y)305.49%
Cap/Depr(5y)251.79%
Cap/Sales(3y)12.19%
Cap/Sales(5y)11.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-101.8%
EPS 3Y-26.43%
EPS 5Y-30.77%
EPS Q2Q%-196.87%
EPS Next Y267.99%
EPS Next 2Y158.88%
EPS Next 3Y155.63%
EPS Next 5Y81.59%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.34%
Revenue Next Year22.66%
Revenue Next 2Y18.19%
Revenue Next 3Y22.22%
Revenue Next 5Y13.59%
EBIT growth 1Y-69.65%
EBIT growth 3Y23.71%
EBIT growth 5Y0.24%
EBIT Next Year42.92%
EBIT Next 3Y34.74%
EBIT Next 5Y27.13%
FCF growth 1Y-391.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25.31%
OCF growth 3YN/A
OCF growth 5Y25.02%